The hottest medical device industry focuses on the

The medical device industry focuses on the era of new medical reform

the 12th Five Year Plan boosts market confidence

the medical imaging area is the largest exhibition area in the CMEF professional division. Its products cover the fields of radiation, ultrasound, nuclear medicine and intervention disciplines, involving 15 categories. All well-known enterprises at home and abroad, such as Xinhua medical, Mairui, Neusoft, Wandong, Ruike, Yuyue, Ge, Siemens, Philips, Shimadzu, etc., participated in the exhibition. However, the medical informatization and other IT exhibition areas are significantly smaller than the Shenzhen exhibition in April this year. Insiders believe that traditional equipment manufacturing enterprises need this form of centralized display more

it was found that the 12th Five Year Plan for medical devices, which was widely rumored to be introduced, has become a hot topic for exhibitors. The relevant person in charge of the Department of social development of the Ministry of science and technology said that technology research, product research and development, platform construction and base construction will be the development priorities of China's medical device industry during the 12th Five Year Plan period. The industry generally believes that in the future, China will vigorously adjust the development direction and product structure of the medical device industry, support and develop independent intellectual property rights, so as to promote industrial development. Wang Hongguang, director of the China Biotechnology Development Center of the Ministry of science and technology, said that the biotechnology industry is becoming the focus of competition in high-tech industries of various countries, and the bioeconomy is becoming a new global economic growth point. China's biotechnology industry will exceed 6 trillion yuan in 2020. At present, we must speed up the industrialization of scientific and technological achievements

according to sources, the 12th Five Year Plan for the medical device industry will specifically encourage enterprises to increase cooperation with foreign capital and implement the "going out" strategy. In fact, Chinese medical enterprises have set a successful precedent in exploring the American market. Mindray International Medical Co., Ltd., which entered the American market through the acquisition of American enterprises in 2008, has entered the international market with nearly 40% of its independently developed products. The diving medical products have also been certified by Japan, the European Union and other import regions. Chen Jian, the Secretary of the chairman of the board of directors of the company, said that due to the high requirements of international certification on product quality and the high cost of time and other related costs, enterprises that obtain international certification first will have the first mover advantage, and competitors will be difficult to surpass in the short term

according to the data from the medical insurance chamber of Commerce, the export growth rate of the medical device industry in the second half of this year is expected to continue the rapid momentum of the first half of the year, and the annual growth rate will reach 18% - 20%. Medical devices made in China are becoming the target of choice for more and more international manufacturers with high cost performance. Developing overseas strategy is the unswerving goal of Yangpu medical. Dengguanhua, chairman of Guangzhou Yangpu Medical Technology Co., Ltd., told that until it broke, taking vacuum blood collection vessels as an example, China's per capita consumption of less than one a year, while Japan's per capita consumption of four, the United States is 10. It is reported that the consumption of medical devices in the U.S. medical market accounts for 40% - 50% of the total medical consumption. In contrast, there is huge room for the development of China's medical device industry

guofanli, a researcher in the pharmaceutical industry of CIC consulting, believes that according to the outline of the national medium and long term scientific and technological development plan, in the future, the development of medical devices in China will be divided into two levels: on the one hand, technology and product research and development. With the steady implementation of the new medical reform, chitosan can be identified through two indicators: appearance (the whiter the appearance, the better) and deacetylation degree (the higher the deacetylation degree, the better). At present, increasing the research and development of medical device products is the focus. The other is the construction of industrial platforms and bases. In this regard, it is urgent to change the situation of scattered, disordered and poor to achieve healthy development

high end equipment is still favored

due to the launch of the new medical reform, hospitals have more vitality. High end equipment is no longer unique to grade III and grade A hospitals. Many secondary hospitals have also purchased CT, MRI and other high-end inspection equipment, which makes the whole market look extremely popular. We originally planned to sell only 10 sets of equipment this year, but we didn't expect the order volume to reach 25 sets. China's medical market is too hot! According to stern, an American medical equipment company: "2015 has been a very successful and pleasant year. Industry insiders believe that based on the huge population base and relatively lagging equipment level, the demand for high-end equipment in the Chinese market will continue to grow steadily in the next five years.

at this CMEF, robotic surgical hand systems and other high-tech equipment have appeared frequently. An expert told that surgical robots can be used in heart surgery, Urology, obstetrics and Gynecology, and hand resection Completely replace hands in surgery and transplantation. The manipulator completely imitates the action of human wrist, and its control force is far more than that of human hand. It has the advantages of stable and non fatigue manipulator, and is more flexible than human hand in narrow anatomical areas. It can effectively shorten the hospitalization time of patients, reduce surgical complications and surgical bleeding. A newborn ventilator specially designed for premature infants and children at the medical Expo also attracted great interest from participants. This ventilator is triggered by the child every time. The timing of each breath is closely linked with the human body, which can effectively reduce the work of breathing, shorten the time of withdrawal, help exercise the respiratory muscles while ensuring sufficient oxygen supply, and promote the respiratory muscles of premature infants to mature as soon as possible

however, some experts pointed out that domestic high-end products are still very scarce. Chenyazhu, an academician of the Chinese Academy of Sciences, said that at present, China's medical device industry still has problems such as lack of independent innovative products, excessive dependence on imported products, and backward devices in grass-roots medical institutions. According to the data from Shanghai Medical Device Industry Association, the output value of Shanghai medical device industry was about 12billion yuan in 2009, with a year-on-year increase of 17.4%. However, among the first, second and third categories of medical devices, the relatively high-end three categories of products (such as implantable devices) accounted for only about 20%. A doctor who visited the exhibition said that the high-quality consumables such as artificial joints used in his hospital were not local products, only commonly used domestic products such as cotton gauze. Experts said that in the export structure of domestic medical devices, surgical towels, massage instruments and so on are still traditional projects, and most domestic enterprises have not formed landmark products and core competitiveness

Yu mengsun, director of the Air Force Institute of Aeronautical medicine, aeronautical Medicine Engineering Research Center and academician of the Chinese Academy of engineering, believes that an important reason for the high cost of medical treatment lies in the medical devices, and the inspection and treatment fees are very expensive. On the one hand, the price of these instruments purchased by the hospital is high, on the other hand, the items of examination and treatment are divided too carefully, and the medical process is becoming more and more complex. When a wide range of examinations and treatments are added together, the cost is naturally high. Academician Yu mengsun pointed out that China's medical treatment should shift from disease treatment to health maintenance. At the same time, in health maintenance and disease treatment, we should pay attention to the regulation and treatment of people's overall state, rather than dividing detection and treatment into small items and separating them

in fact, the localization of high-end devices can greatly reduce medical costs. For example, the cardiovascular stent product developed by minimally invasive medical devices (Shanghai) Co., Ltd. over 10 years has reduced the cost by more than 50% compared with the imported stent of more than 30000 yuan. Minimally invasive cost-effective products have also significantly reduced the price of foreign products to more than 10000 yuan, and ultimately benefit patients. Specific industrial policy support is also needed to promote the independent development of the medical device industry. Chen Yazhu said that the scientific and technological achievements of medical devices need at least three to five years of transformation period, and they cannot be produced without an input of 10 or 20 million yuan. This requires relevant departments to promote them with policy funds and other ways to help enterprises with good prospects complete the whole process

expansion effect of medical reform

ten years ago, second-class and first-class hospitals all hoped to establish large and complete self owned laboratory departments, which brought heavy pressure on equipment and personnel costs to hospitals. Today, more and more local governments begin to accept the outsourcing of some testing and CT businesses to third-party institutions such as independent laboratories, in order to save medical resources and reduce hospital operating costs. Cong Yulong, President of the branch of laboratory physicians of the Chinese Medical Association, told that the total output value of China's in vitro diagnosis industry was 4.4 billion yuan in 2006, 6 billion yuan in 2008, and is expected to reach 12.9 billion yuan by 2012. According to Yu Long, the rapid development of in vitro diagnosis industry has put forward higher requirements for the market analysis and decision-making ability of industry managers, the quality and innovation level of scientific researchers

Jinyu is developing very fast, and the market demand for third-party inspection exceeds our expectations. As the first independent laboratory to obtain the "medical institution practice license" in China, Jinyu testing entered the field of medical testing services in 1994. Now it has established comprehensive testing centers of a certain scale in Guangzhou, Nanjing, Jinan, Xi'an, Hefei, Zhengzhou, Chongqing, Changchun, Kunming, Changsha, Guiyang and Shenyang. Liang Yaoming, chairman of Jinyu, said that with the gradual deepening of the new medical reform, the medical and health industry is undergoing a profound structural change

old brand manufacturing enterprises such as Ruike medical are also constantly expanding new fields. The theme of this exhibition is "Tao, medical system solutions". Ruike, Ge, Neusoft and other enterprises have launched overall solutions, covering equipment, software, follow-up services and information platforms. For example, Ruike's DRX magic family provides radiologists with a more intimate solution. At present, digital radiography in the market focuses on Cr and Dr, but there is no product that can give consideration to the advantages of both. Magic card DR can also carry out zigzag corrosion experiment. X-1 fills this gap and is suitable for a variety of ordinary radiography applications. Magic card DRX-1 can convert traditional ray or computer-aided ray imaging system into DR in 5 seconds. At the same time, compact imaging equipment is gradually forming a climate, and many companies have released compact X-ray machines, CT or other equipment. In addition, due to the relatively rapid growth of female breast cancer patients in China, companies including Siemens have launched a complete set of female care solutions

He Wei, director of the Department of science and education of the Ministry of health, pointed out that the health of Chinese people is facing many challenges. On the basis of a large population, the medical device industry plays an important supporting role in medical security. In order to reduce the cost of seeing a doctor, we must develop China's own high-tech medical devices. The rapid development of computer technology, networking technology, microelectronics technology, precision processing technology and new material technology has also accelerated the technological innovation and product upgrading of the medical device industry. China must keep up with this rapid pace. With technological progress, China's medical device enterprises have risen rapidly, gradually realizing import substitution, and breaking through from the middle and low-end market to the high-end market. At the same time, under the background of reducing medical and health costs in various countries, the product export of China's medical device enterprises will face unprecedented development opportunities. The medical device industry involves interdisciplinary technologies, and the industry is characterized by many, small, scattered and large span. The improvement of industry concentration and industry integration is the general trend. Over time, Chinese local enterprises with excellent genes will stand out

Yang Xiaohao of Huachuang Securities believes that the growth rate of China's medical device market has always been faster than that of the pharmaceutical market in the past 10 years. Even so, China's medical device industry is still in its infancy. At present, the market scale of medical devices in China accounts for 14% of the total market scale of medicine. Compared with 42% of the total market scale of medicine in the world, there is a huge development space brought about by the adjustment of consumption structure, which is not expected